Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 USD | +10.98% | +32.41% | +9.09% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 94.15M |
---|---|---|---|---|---|
Net income 2024 * | -33M | Net income 2025 * | -45M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.37
x | P/E ratio 2025 * |
-3.05
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.41% |
Latest transcript on Corvus Pharmaceuticals, Inc.
1 day | +10.98% | ||
1 week | +32.41% | ||
Current month | +23.87% | ||
1 month | +9.71% | ||
3 months | -8.57% | ||
6 months | +40.15% | ||
Current year | +9.09% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 14-01-26 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 14-01-26 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 14-01-26 |
Ian Clark
BRD | Director/Board Member | 62 | 17-01-02 |
Terry Gould
BRD | Director/Board Member | 67 | 14-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.92 | +10.98% | 381,059 |
24-05-02 | 1.73 | +7.45% | 453,252 |
24-05-01 | 1.61 | +3.87% | 80,682 |
24-04-30 | 1.55 | -1.90% | 56,501 |
24-04-29 | 1.58 | +8.97% | 131,930 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.09% | 94.15M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- CRVS Stock